SPCB (SPCB) Stock Price & Analysis
SPCB (SPCB) fell 1.59% to USD 9.92 as of September 8, 2026 at 12:43 UTC, according to Nexqual real-time market data.
SPCB last closed at USD 10.08; the session ranged USD 9.86–10.16 on volume of 61,524 shares. Market capitalization is $62.30M, with a 52-week range of USD 7.07–13.57 (NCM). Source: Nexqual, September 8, 2026 at 12:43 UTC.
Key Statistics (as of September 8, 2026 at 12:43 UTC)
| Price | USD 9.92 |
|---|---|
| Change | ▼ 1.59% (down) |
| Previous Close | USD 10.08 |
| Open | USD 10.02 |
| Day Range | USD 9.86 – 10.16 |
| 52-Week Range | USD 7.07 – 13.57 |
| Volume | 61,524 shares |
| Market Cap | $62.30M |
| Exchange | NCM |
Technical Analysis (SPCB)
Nexqual's technical model rates SPCB "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 12:43 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 37.68 (neutral) |
| vs SMA50 | Below (USD 10.86) |
| MACD | -0.22 (negative) |
Analyst Ratings (SPCB)
Wall Street analysts rate SPCB "None" based on 2 analysts, with a mean price target of USD 17 (range USD 16–18), per Nexqual as of September 8, 2026 at 12:43 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 17 |
| High Target | USD 18 |
| Low Target | USD 16 |
| Buy / Hold / Sell | 2 / 0 / 0 |
Earnings (SPCB)
| Next Earnings Date | 2026-11-12 |
|---|---|
| EPS Estimate | USD 0.15 |
| Revenue Estimate | $6.95M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.52 vs est 0.28 ▲ beat |
| 2026-03-31 | USD 0.51 vs est 0.18 ▲ beat |
| 2025-12-31 | USD 0.36 vs est 0 ▲ beat |
| 2025-09-30 | USD 0.39 vs est -0.02 ▲ beat |
Source: Nexqual, September 8, 2026 at 12:43 UTC.
Financials & Fundamentals (SPCB)
| Total Revenue | $29.41M |
|---|---|
| Revenue Growth (YoY) | +13.30% |
| Gross Margin | +55.77% |
| Operating Margin | +10.61% |
| Profit Margin | +2.92% |
| ROE | +2.02% |
| Debt / Equity | 48.46 |
| Current Ratio | 5.75 |
| Total Cash | $7.43M |
| Total Debt | $23.16M |
Source: Nexqual, September 8, 2026 at 12:43 UTC.
Financial Health Score (SPCB)
Nexqual rates SPCB's overall financial health "Mixed" across five dimensions, as of September 8, 2026 at 12:43 UTC.
| Growth | Mixed — Revenue +0.9% YoY (annual), slow |
|---|---|
| Profitability | Weak — Small revenue base — building scale |
| Balance Sheet | Strong — $7M cash vs $23M debt |
| Cash Flow | Mixed — No data |
| Efficiency | Weak — ROE 2%, ROA -0.5% |
Ownership (SPCB)
| Insider Ownership | +8.88% |
|---|---|
| Institutional Ownership | +18.97% |
| Shares Outstanding | 6.28M |
| Float | 5.47M |
| Short % of Float | +2.08% |
Source: Nexqual, September 8, 2026 at 12:43 UTC.
Leadership (SPCB)
SPCB is led by Ordan Trabelsi (age 41), President & CEO, per Nexqual as of September 8, 2026 at 12:43 UTC.
| President & CEO | Ordan Trabelsi (age 41) |
|---|---|
| Vice President of Sales at Safend Ltd | Gil Alfi (age 46) |
| Director of R & D | Yoad Hayash |
| Acting CFO & Director | Arie Trabelsi (age 67) |
| Managing Director of LCA, USA | Lester Villeneuve (age 57) |
Major Backers & Investors (SPCB)
Notable institutional backers of SPCB include Stifel Financial Corporation, Corsair Capital Management, L.P., Apis Capital Advisors, LLC, according to Nexqual as of September 8, 2026 at 12:43 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Stifel Financial Corporation | 3.36% |
| Corsair Capital Management, L.P. | 3.29% |
| Apis Capital Advisors, LLC | 2.16% |
| Jane Street Group, LLC | 1.05% |
| Morgan Stanley | 0.92% |
| Citadel | 0.7% |
| Quadrature Capital Ltd | 0.45% |
| Renaissance Technologies | 0.43% |
Source: Nexqual, September 8, 2026 at 12:43 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SNES | SenesTech, Inc. | USD 1 | ▼ 5.66% |
| SXTC | China SXT Pharmaceuticals, Inc. | USD 2.23 | ▲ 0.45% |
| CETX | Cemtrex Inc. | USD 2.5 | ▼ 0.79% |
| CFOR | CapForce Inc. | USD 5.15 | ▲ 0% |
| OLOX | Olenox Industries Inc. | USD 0.86 | ▼ 16.18% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 12:43 UTC. This page is informational and not investment advice.